Evidence map›Paper›PMID 11781390›Full record

ArticleJournal of leukocyte biology2002

Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress.

Jianguo Du, Jing Luan, Hua Liu, Thomas O Daniel, Stephen Peiper, Theresa S Chen, Yingchun Yu, Linda W Horton, Lillian B Nanney, Robert M Strieter and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Lung Angiogenesis Requires CD4(+) Forkhead Homeobox Protein-3(+) Regulatory T Cells.American journal of respiratory cell and molecular biology · 2015
    Article
  10. Review
  11. Review
  12. Review
  13. CXCR2: a target for pancreatic cancer treatment?Expert opinion on therapeutic targets · 2013
    Review
  14. Article
  15. Article
  16. Chemokines in health and disease.Experimental cell research · 2011
    Review
  17. Atypical chemokine receptors.Experimental cell research · 2011
    Review
  18. Review
  19. Platelet-derived chemokines: pathophysiology and therapeutic aspects.Cellular and molecular life sciences : CMLS · 2010
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Jianguo DuDepartment of Veterans Affairs and Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
Jing Luan
Hua Liu
Thomas O Daniel
Stephen Peiper
Theresa S Chen
Yingchun Yu
Linda W Horton
Lillian B Nanney
Robert M Strieter
Ann Richmond
Nashville Oncology Associates · USJames Graham Brown Foundation · USUniversity of California, Los Angeles · USUniversity of Louisville · USVanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
UV, APOPTOSIS, PROTEIN PHOSPHATASE AND SKIN DISEASEP30AR041943 · NIAMS · VANDERBILT UNIVERSITY · PI MCCAWLEY, LISA JOY · 1994 to 2008
$5.3M
MELANOMA GROWTH STIMULATORY ACTIVITYR01CA034590 · NCI · VANDERBILT UNIVERSITY · PI RICHMOND, ANN · 1986 to 2017
$5.2M
CXC Chemokines in CancerR01CA087879 · NCI · UNIVERSITY OF VIRGINIA · PI STRIETER, ROBERT M · 2000 to 2010
$3.4M
Chemokines and Fibrocytes in Acute Lung InjuryR01HL066027 · NHLBI · UNIVERSITY OF VIRGINIA · PI STRIETER, ROBERT M · 2001 to 2009
$3.2M
TYROSINE PHOSPHATASES IN ENDOTHELIAL GROWTH CONTROLR01DK038517 · NIDDK · VANDERBILT UNIVERSITY · PI TAKAHASHI, TAKAMUNE · 1987 to 2009
$2.8M
BLRD VA IK6 BX005225NCI NIH HHS CA68485NCI NIH HHS CA87879NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA034590NCI NIH HHS R01 CA087879NHLBI NIH HHS HL66027NHLBI NIH HHS R01 HL066027NIAMS NIH HHS AR41943NIAMS NIH HHS P30 AR041943NIDDK NIH HHS DK38517NIDDK NIH HHS R01 DK038517
6 · The paper itself

Abstract

CXC chemokines, which induce angiogenesis, have glutamine-leucine-arginine amino acid residues (ELR motif) in the amino terminus and bind CXCR2 and the Duffy antigen chemokine-binding protein. Duffy, a seven transmembrane protein that binds CXC and CC chemokines, has not been shown to couple to trimeric G proteins or to transduce intracellular signals, although it is highly expressed on red blood cells, endothelial cells undergoing neovascularization, and neuronal cells. The binding of chemokines by Duffy could modulate chemokine responses positively or negatively. Positive regulation could come through the presentation of chemokine to functional receptors, and negative regulation could come through Duffy competition with functional chemokine receptors for chemokine binding, thus serving as a decoy receptor. To determine whether Duffy has a role in angiogenesis and/or maintenance of homeostasis, we developed transgenic mice expressing mDuffy under the control of the preproendothelin promoter/enhancer (PPEP), which directs expression of the transgene to the endothelium. Two PPEP-mDuffy-transgenic founders were identified, and expression of the transgene in the endothelium was verified by Northern blot, RT-PCR, and immunostaining of tissues. The phenotype of the mice carrying the transgene appeared normal by all visual parameters. However, careful comparison of transgenic and nontransgenic mice revealed two phenotypic differences: mDuffy-transgenic mice exhibited a diminished angiogenic response to MIP-2 in the corneal micropocket assay, and mDuffy-transgenic mice exhibited enhanced hepatocellular toxicity and necrosis as compared with nontransgenic littermates in response to overdose of acetaminophen (APAP; 400 mg/kg body weight). Morover, APAP treatment was lethal in 50% of the mDuffy-transgenic mice 24 h post challenge, and 100% of the nontransgenic littermates survived this treatment at the 24 h time point. Our data suggest that enhanced expression of mDuffy on endothelial cells can lead to impaired angiogenic response to chemokines and impaired maintenance of homeostasis in response to toxic stresses.

Indexed as

Antigens, ProtozoanProtozoan ProteinsAcetaminophenAnalgesics, Non-NarcoticAnimalsCarrier ProteinsChemokines, CXCEndothelium, CornealHomeostasisLiverMiceMice, TransgenicNecrosisNeovascularization, PathologicReceptors, Cell SurfaceReceptors, Interleukin-8BAcetaminophenAnalgesics, Non-NarcoticAntigens, ProtozoanCarrier ProteinsChemokines, CXCDuffy antigen binding protein, PlasmodiumProtozoan ProteinsReceptors, Cell SurfaceReceptors, Interleukin-8B

Identifiers

PMID11781390
PMCPMC2665273
OpenAlexW1902035535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.